“A Multi-Center, Open-Label Extension Study to Assess the Long-Term Safety, Tolerability and Pharmacokinetics, and Explore the Efficacy of Sofpironium Bromide Gel, 15% Applied Topically to Children Adolescents, 9-16 Years, With Primary Axillary Hyperhidrosis”. SKIN The Journal of Cutaneous Medicine 4, no. 6 (October 27, 2020): s116. Accessed October 13, 2025. https://skin.dermsquared.com/skin/article/view/1089.